International Journal of Family Medicine / 2012 / Article / Tab 3

Research Article

Chronic Condition Clusters and Polypharmacy among Adults

Table 3

Weighted percentage with polypharmacy. Unadjusted and adjusted odds ratio and 95% confidence intervals for chronic condition clusters. From logistic regressions on polypharmacy. Medical Expenditure Panel Survey, 2009.

Weighted percentage with polypharmacyEstimates from logistic regressions on polypharmacy
PercentageOR95% CISig.AOR95% CISig.

CM18.30.13(0.10, 0.15) ***0.23(0.18, 0.30) ***
Resp.7.20.04(0.03, 0.07) ***0.15(0.09, 0.24) ***
Musc.7.90.05(0.04, 0.06) ***0.09(0.06, 0.13) ***
CM  and  Musc.41.20.39(0.32, 0.48) ***0.45(0.35, 0.57) ***
CM  and  Resp.41.80.40(0.30, 0.55) ***0.53(0.38, 0.75) ***
Musc. and  Resp.28.30.22(0.15, 0.32) ***0.32(0.21, 0.48) ***
CM, Resp. and  Musc.64.1(Reference group)

CM18.3(Reference group)
Musc.7.90.38(0.31, 0.48) ***0.38(0.30, 0.49) ***
Resp.7.20.35(0.24, 0.52) ***0.62(0.40, 0.96) *

Musc.7.9(Reference group)
Resp.7.20.91(0.59, 1.39)1.62(1.01, 2.60) *

CM  and  Musc..41.2(Reference group)
CM  and  Resp41.81.03(0.80, 1.32)1.19(0.92, 1.54)

Musc. and  Resp.28.3(Reference group)
CM and Musc.41.21.77(1.29, 2.42) ***1.42(1.00, 2.01)
CM  and  Resp.41.81.82(1.25, 2.65) **1.68(1.11, 2.56) *

Note: Based on 10,528 adults alive at the end of 2009, reported having at least one chronic condition (cardio-metabolic, musculoskeletal, or respiratory condition). All analyses accounted for complex survey design of the Medical Expenditure Panel Survey. The regressions also include intercept terms and parameter estimates for other variables controlled are not presented. Asterisks represent statistically significant group differences compared to the reference group. “0 to 5 drugs” is the reference group for the dependent variable. CM: cardio-metabolic; Musc.: musculoskeletal; Resp.: respiratory; Wt: weighted; OR: Odds ratio; AOR: adjusted Odds ratio; CI: confidence interval.
; ; .